Müllerian duct cyst: Case report with updates in cellular origin, corresponding immunohistochemistry, and contrast to prostatic utricle cyst.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 26 07 2021
revised: 06 10 2021
accepted: 12 10 2021
pubmed: 27 10 2021
medline: 4 3 2022
entrez: 26 10 2021
Statut: ppublish

Résumé

A 20-year-old male presented to the emergency department with lower abdominal pain, urinary retention, and constipation. Computed tomography (CT) revealed a large cyst on the posterior aspect of the prostate gland; he was ultimately diagnosed with a Müllerian duct cyst (MDC). Although much has been written on the radiologic diagnosis of such cysts, there is a paucity of recent literature concerning the pathological diagnosis. While older studies debated the Müllerian origin of a midline cyst abutting the poster prostate, we believe that with the advent of monoclonal PAX8 (which was positive in this lesion) and monoclonal PAX2 (which was negative), we have strong evidence that the present cyst is indeed of Müllerian origin. Further, there is debate in the literature as to whether MDC is synonymous or distinct from prostatic utricle cyst. We present an interdisciplinary analysis as to the merits and weaknesses of both sides of the debate and how data gathered from the current case could be used in a future, larger study to arrive at a more definitive conclusion.

Identifiants

pubmed: 34700015
pii: S0344-0338(21)00318-6
doi: 10.1016/j.prp.2021.153657
pii:
doi:

Substances chimiques

Biomarkers 0
PAX8 Transcription Factor 0
PAX8 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153657

Informations de copyright

Copyright © 2021 Elsevier GmbH. All rights reserved.

Auteurs

Benzion Samueli (B)

Department of Pathology, Soroka University Medical Center, Be'er Sheva, Israel; Medical School for International Health, Ben Gurion University of the Negev, Faculty of Health Sciences, Be'er Sheva, Israel. Electronic address: BenziS@post.bgu.ac.il.

Elad Mazor (E)

Department of Urology, Soroka University Medical Center, Be'er Sheva, Israel.

Iris Kamenev (I)

Medical School for International Health, Ben Gurion University of the Negev, Faculty of Health Sciences, Be'er Sheva, Israel.

Gal Ben-Arie (G)

Medical School for International Health, Ben Gurion University of the Negev, Faculty of Health Sciences, Be'er Sheva, Israel; Department of Radiology, Soroka University Medical Center, Be'er Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH